BRAF and colorectal carcinoma: Conversely, the CCLE dataset, which comprised 57 CRC cell lines with BRAF mutation data [39], showed that the BRAF mutation status had no significant impact on the levels of TBSS, likely due to its stromal specificity (Figure 2f).